| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Cash and cash equivalents at beginning of period | 32,739 | - |
| Gain on disposal of assets | - | 931 |
| Net loss | -8,059 | -1,313 |
| Depreciation and amortization | 9,608 | 5,929 |
| Amortization and write off of debt issuance cost | 123 | 87 |
| Amortization and write off of discount on long-term debt | 5,995 | 3,664 |
| Change in contingent consideration from acquisitions | 7,482 | 10,553 |
| Non-cash lease expense | 3,173 | 2,207 |
| Change in tax receivable agreement liability | -1,331 | -1,975 |
| Bad debt expense | 2,786 | 1,163 |
| Equity-based compensation | 8,341 | 5,947 |
| Non-cash interest | -1,552 | -747 |
| Gain on disposal of assets and lease terminations | 5,021 | - |
| Gain on divestitures | 4,866 | - |
| Impairment of goodwill and other noncurrent assets | 32,411 | 14,843 |
| Accounts receivable | -4,517 | 11,949 |
| Inventories | -4,355 | -2,624 |
| Prepaid expenses and other current assets | 12,344 | 4,146 |
| Operating lease liabilities | -2,772 | -1,934 |
| Deferred costs | -6,146 | -2,065 |
| Notes receivable, net | -3 | -1 |
| Accounts payable | -11,390 | -4,662 |
| Accrued expenses | 1,994 | 12,127 |
| Other current liabilities | -3,837 | -2,417 |
| Deferred revenue | -17,537 | -7,335 |
| Other assets | -1,547 | -1,296 |
| Other liabilities | 10,170 | 400 |
| Net cash provided by operating activities | 17,640 | 8,341 |
| Purchases of property and equipment | 3,070 | 1,992 |
| Proceeds from sale of assets | 0 | 0 |
| Purchase of intangible assets | 1,224 | 803 |
| Notes receivable issued | 173 | 173 |
| Notes receivable payments received | 169 | 108 |
| Proceeds from disposition of brands | 2,000 | - |
| Acquisition of business | 0 | 0 |
| Net cash used in investing activities | -2,298 | -2,860 |
| Borrowings from long-term debt | 10,000 | 10,000 |
| Payments on long-term debt | 4,123 | 2,748 |
| Debt issuance costs | 90 | 90 |
| Payment of preferred stock dividend | 5,694 | - |
| Payment of promissory note liability | 3,392 | - |
| Payments of contingent consideration | 500 | 500 |
| Payments for taxes related to net share settlement of restricted share units | 2,296 | 2,097 |
| Payment of preferred stock dividend and deemed cash dividend | - | 3,796 |
| Proceeds from issuance of common stock in connection with stock-based compensation plans | 122 | 122 |
| Payments for tax receivable agreement | 0 | 0 |
| Payments for distributions to pre-ipo llc members | 483 | 432 |
| Payment received from shareholder (note 10) | 0 | 0 |
| Reimbursement from shareholder (note 10) | 162 | - |
| Net cash provided by (used in) financing activities | -6,618 | 459 |
| Increase in cash, cash equivalents and restricted cash | 8,724 | 5,940 |
| Cash and cash equivalents at end of period | 41,463 | - |
Xponential Fitness, Inc. (XPOF)
Xponential Fitness, Inc. (XPOF)